This week, we caught up with Farbod Shakouri of Phantom Technology, a returning guest who’s undergone a significant pivot in his startup’s journey. Originally focused on building an operating system for smart glasses, Farbod and his team made a bold decision: to build the entire hardware and software stack themselves. Their mission? To help people combat smartphone addiction and improve cognitive health.

If you’re a founder, investor, or tech enthusiast, this episode is packed with insights on:

· The evolving AI debate & public perception

· How Cambridge startups are tackling energy-efficient computing

· The hard truths of startup pivots & funding strategies

· Why attention-tracking wearables might be the next big thing

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

This week, we sat down with Nick New, CEO of Optalysys, to explore the groundbreaking technology transforming data security, AI, and cloud services. From optical processing to fully homomorphic encryption (FHE), this episode dives into the cutting-edge innovations driving the next era of secure computing.

Nick shares:

· His journey from his PhD in optical pattern recognition to founding Optalysys.

· How Optalysys leverages optical processing and FHE to process encrypted data without ever decrypting it—ushering in a new standard for secure AI and cloud computing.

· Optalysys’s big win at the Cambridge Tech Week Scale Up Awards and their plans for product launches, blockchain applications, and setting up a U.S office.

· Their mission to establish global hardware standards for FHE as part of the FETCH consortium.

· And, Optalysys's vision to become the “Nvidia of FHE.”

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

In this episode we hear from the winners of The Trinity Bradfield Prize:

· Demetria who aims to reduce the time it takes for an endometriosis diagnosis from nine years to nine minutes using AI-assisted ultrasound.

· PowerMatrix who provide the most efficient and compact next-generation high-performance power supplies.

· Healthspan Biotics who develop and distribute safe, affordable and effective probiotic bacteria that enhances brain resilience to Alzheimer’s disease.

This year’s awards also saw the introduction of the Angel Prize which recognises the most commercial progress over the previous 12 months from winning the competition. The prize was split between BioTryp Therapeutics and Cambridge Nucleomics.

The winners also discuss their experiences during the competition, highlight the importance of networking and skill development for founders, and share their funding needs and expertise requirements.

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.